A phase I trial of mRNA-1851

Trial Profile

A phase I trial of mRNA-1851

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 14 Sep 2017

At a glance

  • Drugs MRNA 1851 (Primary)
  • Indications Infections
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 14 Sep 2017 According to a Moderna Therapeutics media release, complete findings are expected in 2018.
    • 14 Sep 2017 Status changed from recruiting to active, no longer recruiting, according to a Moderna Therapeutics media release.
    • 27 Apr 2017 According to a Moderna Therapeutics media release, 156 healthy volunteers have been dosed in this study till date.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top